Arrowstreet Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $34.2M | Buy |
|
|||||
|
2024
Q4 | $11.5M | Sell |
|
|||||
|
2024
Q3 | $1.44B | Buy |
|
|||||
|
2024
Q2 | $1.46B | Buy |
|
|||||
|
2024
Q1 | $909M | Buy |
|
|||||
|
2023
Q4 | $548M | Sell |
|
|||||
|
2023
Q3 | $790M | Buy |
|
|||||
|
2023
Q2 | $648M | Sell |
|
|||||
|
2023
Q1 | $497M | Sell |
|
|||||
|
2022
Q4 | $707M | Sell |
|
|||||
|
2022
Q3 | $803M | Sell |
|
|||||
|
2022
Q2 | $1.16B | Buy |
|
|||||
|
2022
Q1 | $948M | Buy |
|
|||||
|
2021
Q4 | $591M | Buy |
|
|||||
|
2021
Q3 | $244M | Buy |
|
|||||
|
2021
Q2 | $15M | Sell |
|
|||||
|
2021
Q1 | $76.7M | Sell |
|
|||||
|
2020
Q4 | $142M | Sell |
|
|||||
|
2020
Q3 | $184M | Buy |
|
|||||
|
2020
Q2 | $148M | Buy |
|
|||||
|
2020
Q1 | $31.4M | Buy |
|
|||||
|
2019
Q4 | $15.4M | Sell |
|
|||||
|
2019
Q3 | $133M | Sell |
|
|||||
|
2019
Q2 | $156M | Buy |
|
|||||
|
2019
Q1 | $81.4M | Sell |
|
|||||
|
2018
Q4 | $262M | Sell |
|
|||||
|
2018
Q3 | $390M | Buy |
|
|||||
|
2018
Q2 | $206M | Buy |
|
|||||
|
2018
Q1 | $181M | Buy |
|
|||||
|
2017
Q4 | $94.6M | Buy |
|
|||||
|
2017
Q3 | $31.4M | Sell |
|
|||||
|
2017
Q2 | $99.8M | Buy |
|
|||||
|
2017
Q1 | $7.15M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $32.6M | Sell |
|
|||||
|
2016
Q2 | $64.1M | Sell |
|
|||||
|
2016
Q1 | $121M | Buy |
|
|||||
|
2015
Q4 | $41.4M | Sell |
|
|||||
|
2015
Q3 | $57.9M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $1.29M | Sell |
|
|||||
|
2014
Q4 | $27.4M | Sell |
|
|||||
|
2014
Q3 | $92.5M | Sell |
|
|||||
|
2014
Q2 | $114M | Buy |
|
|||||
|
2014
Q1 | $3.21M | Sell |
|
|||||
|
2013
Q4 | $81.2M | Sell |
|
|||||
|
2013
Q3 | $214M | Sell |
|
|||||
|
2013
Q2 | $212M | Buy |
|